Sonnet BioTherapeutics Holdings, Inc. (SONN)

NASDAQ: SONN · IEX Real-Time Price · USD
0.265
+0.002 (0.65%)
At close: Jul 6, 2022 4:00 PM
0.253
-0.012 (-4.607%)
Pre-market: Jul 7, 2022 5:12 AM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Year 2021202020192018201720162015201420132012 2011 - 2004
Revenue
0.480030.7341.4341.735.3529.848.256.85
Upgrade
Revenue Growth (YoY)
----25.82%-0.65%17.96%18.46%261.85%20.36%364.05%
Upgrade
Cost of Revenue
00028.1337.1336.0331.4327.37.946.55
Upgrade
Gross Profit
0.48002.614.315.673.922.550.310.31
Upgrade
Selling, General & Admin
8.947.532.513.864.555.86.85.984.232.31
Upgrade
Research & Development
16.639.882.20000000
Upgrade
Other Operating Expenses
06.8304.1252.492.22.110.680.59
Upgrade
Operating Expenses
25.5724.244.717.989.548.2998.094.912.9
Upgrade
Operating Income
-25.09-24.24-4.71-5.37-5.24-2.62-5.08-5.54-4.61-2.59
Upgrade
Interest Expense / Income
000.162.552.592.353.472.280.760.47
Upgrade
Other Expense / Income
-0.10.030-0.36-0.393.913.4-0.95-0.190.08
Upgrade
Pretax Income
-24.98-24.27-4.87-7.56-7.44-8.88-11.95-6.88-5.17-3.15
Upgrade
Income Tax
000-0.7-0.640.20.19-0.480.040.02
Upgrade
Net Income
-24.98-24.27-4.87-6.85-6.79-9.08-12.14-6.4-5.21-3.17
Upgrade
Preferred Dividends
041.3400.120.1100000
Upgrade
Net Income Common
-24.98-65.6-4.87-6.97-6.9-9.08-12.14-6.4-5.21-3.17
Upgrade
Shares Outstanding (Basic)
25950000000
Upgrade
Shares Outstanding (Diluted)
25950000000
Upgrade
Shares Change
160.57%76.14%3850.24%39.41%16.39%52.29%124.95%45.07%71.75%114.48%
Upgrade
EPS (Basic)
-1.02-6.96-0.91-51.48-70.98-108.68-221.00-265.20-312.00-325.00
Upgrade
EPS (Diluted)
-1.02-6.96-0.91-51.48-70.98-108.68-221.00-265.20-312.00-325.00
Upgrade
Free Cash Flow Per Share
-0.92-1.67-0.42-20.74-19.45-20.27-128.66-123.05-378.94-363.37
Upgrade
Gross Margin
100.00%--8.49%10.40%13.59%11.09%8.53%3.72%4.46%
Upgrade
Operating Margin
-5187.36%---17.47%-12.64%-6.28%-14.37%-18.58%-55.85%-37.82%
Upgrade
Profit Margin
-5165.97%---22.69%-16.66%-21.77%-34.33%-21.46%-63.22%-46.21%
Upgrade
Free Cash Flow Margin
-4663.91%---9.14%-4.56%-4.06%-19.94%-10.04%-77.14%-51.84%
Upgrade
Effective Tax Rate
0.00%0.00%0.00%9.28%8.66%-2.24%-1.57%6.93%-0.79%-0.61%
Upgrade
EBITDA
-24.89-24.21-4.71-3.19-2.56-4.19-6.78-3.01-3.79-2.29
Upgrade
EBITDA Margin
-5146.29%---10.38%-6.19%-10.05%-19.19%-10.09%-45.99%-33.40%
Upgrade
Depreciation & Amortization
0.10.0601.822.282.341.71.590.620.38
Upgrade
EBIT
-24.98-24.27-4.71-5.01-4.85-6.53-8.48-4.6-4.42-2.67
Upgrade
EBIT Margin
-5165.97%---16.29%-11.70%-15.66%-23.99%-15.41%-53.54%-39.00%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).